To confirm the anti-tumor activity of the anti-TM4SF5 monoclonal antibody against colon cancer in vivo, we administered the anti-TM4SF5 antibody into mice bearing tumors pre-established by injection with human or mouse colon cancer cells. Here, TM4SF5 is linked to malignant colon neoplasm.